News for International Biotechnology Trust (IBT.L)

Pandemic-era mRNA technology pioneers, BioNTech and Moderna, are now focusing on developing personalised cancer vaccines.

In an important election year for healthcare policy, International Biotechnology Trust manager Ailsa Craig says a rough patch should now be in the rearview...

International Biotechnology Trust PLC - biotechnology and healthcare sector-focused alternative investment fund, managed by Schroders - On May 8 reports net asset value total return of 11% in six...

Octopus Apollo VCT plcFinal Results Octopus Apollo VCT plc today announces the final results for the year ended 31 January 2024. Octopus Apollo...

International Biotechnology Trust plc Investing in biotechnology for a healthier future Half Year Report For the six...

The UK is a world leader in finding new treatments to tackle diseases

Mar 13, 2024 / 09:00AM GMTRoland Jones - Well, hello, everyone, and welcome to the International Biotechnology Trust Update coming to you today from the Schrod

MIGO Opportunities Trust plcHalf-Yearly Report for the six months ended 31 October 2023 ...

Octopus Apollo VCT plc Director Appointment Octopus Apollo VCT plc  is delighted to announce the appointment of Gillian Elcock as an independent non-executive director of the Company with effect...

The following is a round-up of earnings updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- Wynnstay Properties PLC - Powys, Wales-based...

The following is a round-up of updates by London-listed companies, issued on Wednesday and Tuesday not separately reported by Alliance News: ---------- Grafenia PLC - Manchester-based... | May 3, 2023